Mometasone furoate suspensions for nebulization
US6187765A · kind A · utility
12Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 1998 |
| Grant date | Feb 13, 2001 |
| Priority date | — |
| Expiry date | Oct 6, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aqueous nebulizer suspension contains water, mometasone furoate monohydrate, a nonionic surfactant, a soluble salt and optionally a pH buffer. The suspension may be prepared by ultrasonication or jet milling techniques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.